Skip to main content
. 2019 Feb 26;63(3):e02004-18. doi: 10.1128/AAC.02004-18

TABLE 3.

Micafungin and anidulafungin MICs for the isolates in each used pair to prepare the spiked suspensions in Bactec bottles and FKS2 gene sequence of the tested isolatesa

Pair Isolate EUCAST MYC/AND MIC (mg/liter) FKS2 gene sequence
1 Parental 0.015/0.032 WT
Isogenic 4/2 ΔF658
2 Parental 0.015/0.032 WT
Isogenic 4/2 ΔF658
3 Parental 0.015/0.032 WT
Isogenic 4/2 S663P
4 Parental 0.015/0.032 WT
Isogenic 0.25/0.5 E655A
5 Parental 0.015/0.032 WT
Isogenic 0.064/0.25 WT
6 Parental 0.015/0.015 WT
Isogenic 0.5/0.5 W715L
7 Parental 0.015/0.015 WT
Isogenic 2/1 ΔF658
8 Parental 0.015/0.064 WT
Isogenic 1/2 S663Y
9 Parental 0.015/0.032 WT
Isogenic 0.064/0.5 D666N
10 Parental 0.015/0.032 WT
Isogenic 2/1 S663P
a

MYC, micafungin; AND, anidulafungin. Parental isolates were phenotypically echinocandin susceptible, and isogenic ones were phenotypically echinocandin resistant. Pairs 1 to 8 came from a previous study and involved susceptible isolates from blood samples exposed in vitro to either micafungin or anidulafungin and the corresponding resistant ones generated (27, 28). Pairs 9 and 10 originated in two patients with candidemia who developed concomitant echinocandin-resistant endocarditis. The parental and isogenic isolates in each pair proved to be genotypically identical. WT, wild type.